Renal Cancers Completed Phase 2 Trials for Irofulven (DB05786)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT000033906-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney CancerTreatment